MedPath

Avenacy Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Fosaprepitant

Approval Date
Jul 9, 2025
FDA

Furosemide

Approval Date
Mar 15, 2024
FDA

Dexmedetomidine

Approval Date
Mar 15, 2024
FDA

Fulvestrant

Approval Date
Feb 28, 2024
FDA

Eptifibatide

Approval Date
Jan 31, 2024
FDA

Desmopressin Acetate

Approval Date
Jan 15, 2024
FDA

Melphalan Hydrochloride

Approval Date
Dec 18, 2023
FDA

Bivalirudin

Approval Date
Oct 20, 2023
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.